Reaction Details |
| Report a problem with these data |
Target | MAP kinase-activated protein kinase 3 |
---|
Ligand | BDBM50582077 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_2153004 (CHEMBL5037551) |
---|
IC50 | 1480±n/a nM |
---|
Citation | Elsner, J; Cashion, D; Robinson, D; Bahmanyar, S; Tehrani, L; Fultz, KE; Narla, RK; Peng, X; Tran, T; Apuy, J; LeBrun, L; Leftheris, K; Boylan, JF; Zhu, D; Riggs, JR Structure-Guided Optimization Provides a Series of TTK Protein Inhibitors with Potent Antitumor Activity. J Med Chem64:12670-12679 (2021) [PubMed] Article |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
MAP kinase-activated protein kinase 3 |
---|
Name: | MAP kinase-activated protein kinase 3 |
Synonyms: | 3pK | Chromosome 3p kinase | MAP kinase-activated protein kinase 3 (MAPKAP-K3) | MAPK-Activated Protein Kinase 3 (MK3) | MAPK-activated protein kinase 3 | MAPK3_HUMAN | MAPKAP kinase 3 | MAPKAPK-3 | MAPKAPK3 |
Type: | Serine/threonine-protein kinase |
Mol. Mass.: | 42991.57 |
Organism: | Homo sapiens (Human) |
Description: | Recombinant MAPKAPK3 was phosphorylated by incubation with active p38alpha before assays. |
Residue: | 382 |
Sequence: | MDGETAEEQGGPVPPPVAPGGPGLGGAPGGRREPKKYAVTDDYQLSKQVLGLGVNGKVLE
CFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMEC
MEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKD
AVLKLTDFGFAKETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFP
PFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN
HPWINQSMVVPQTPLHTARVLQEDKDHWDEVKEEMTSALATMRVDYDQVKIKDLKTSNNR
LLNKRRKKQAGSSSASQGCNNQ
|
|
|
BDBM50582077 |
---|
n/a |
---|
Name | BDBM50582077 |
Synonyms: | CHEMBL5085753 |
Type | Small organic molecule |
Emp. Form. | C42H49N9O3 |
Mol. Mass. | 727.897 |
SMILES | CCc1cccc(CC)c1N1CCn2cc(cc2C1=O)-c1nc(Nc2ccc(cc2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)nc2[nH]ccc12 |
Structure |
|